Related Experiment Video
Updated: Dec 13, 2025

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
Published on: May 17, 2024
Experience with Real-Time Continuous Glucose Monitoring in Newborns with Congenital Hyperinsulinemic Hypoglycemia
Ayşe Anık1, Münevver Kaynak Türkmen1, Abdullah Barış Akcan1
1Pediatrics, Division of Neonatology, Adnan Menderes University School of Medicine, Aydin, Turkey.
Insights
Real-time continuous glucose monitoring (RT-CGMS) accurately assesses glucose levels in newborns with congenital hyperinsulinemic hypoglycemia (CHH) during normal blood sugar. This technology can reduce the need for frequent capillary blood tests in these vulnerable infants.
Area of Science:
- Pediatrics
- Endocrinology
- Medical Devices
Background:
- Congenital hyperinsulinemic hypoglycemia (CHH) requires vigilant monitoring in children to prevent neurological damage.
- Current capillary blood glucose monitoring methods are insufficient for detecting all hypoglycemia episodes.
Purpose of the Study:
- To evaluate the accuracy and effectiveness of a real-time continuous glucose monitoring system (RT-CGMS) in neonates diagnosed with CHH.
Main Methods:
- RT-CGMS sensors were used in newborn patients for a minimum of 6 days.
- Bland-Altman analysis was employed to compare RT-CGMS data with capillary blood glucose measurements.
Main Results:
- A high correlation was observed between RT-CGMS and capillary glucose readings, particularly during normoglycemia.
- While the false positive rate for hypoglycemia was notable, RT-CGMS demonstrated potential for earlier detection of hypoglycemic events.
Conclusions:
- RT-CGMS provides accurate glucose monitoring in normoglycemic neonates with CHH.
- The use of RT-CGMS can significantly decrease the number of required capillary blood samples in pediatric CHH patients.
Background:
Effective treatment and close monitoring of hypoglycemia in children with congenital hyperinsulinemic hypoglycemia (CHH) is vital to prevent brain damage. The current use of capillary sampling schedules does not provide a comprehensive assessment of glycemic status and fails to detect asymptomatic hypoglycemia episodes.
Aim:
To investigate the efficacy and accuracy of a real-time continuous glucose monitoring system (RT-CGMS) in neonates with CHH.
Methods:
A sensor connected to RT-CGMS was inserted into the newborn patients and maintained for at least 6 days during their stay in the hospital. We compared the readings of CGMS with capillary blood glucose values using Bland-Altman analysis.
Results:
A total of 110 blood glucose values were compared to readings from the CGMS. All results were calculated and plotted for CGMS values at 0-4, 5-9, 10-14, 15-19, 20-24, and 25-29 min after capillary blood glucose sampling. CGMS readings were highly correlated with blood glucose values, especially during normoglycemia. In case of hypoglycemia, the mean difference between the CGMS and capillary glucose values was higher. Although the false positive rate for hypoglycemia was relatively high in CGMS, RT-CGMS may show some episodes of hypoglycemia earlier than blood measurement.
Conclusion:
RT-CGMS is accurate during normoglycemia, and it can reduce the number of capillary blood samples in children with CHH.
Related Concept Videos
Hypoglycemia and Glucagon
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:

